WHO IS THE SPONSOR?

Finch Research and Development LLC is the sponsor of the PRISM 3 clinical trial, and is a subsidiary of Finch Therapeutics Group, Inc., a U.S.-based biotech company focused on developing and delivering therapies derived from the community of bacteria that live in our gut, termed the gut microbiome.

To learn more about Finch, visit www.finchtherapeutics.com.